In a report released today, David Turkaly from JMP Securities reiterated a Hold rating on Avanos Medical (AVNS – Research Report). The company’s shares opened today at $25.69.
Turkaly covers the Healthcare sector, focusing on stocks such as Apyx Medical, Lantheus, and OrthoPediatrics. According to TipRanks, Turkaly has an average return of 0.7% and a 43.75% success rate on recommended stocks.
Currently, the analyst consensus on Avanos Medical is a Hold with an average price target of $28.50.
See Insiders’ Hot Stocks on TipRanks >>
AVNS market cap is currently $1.19B and has a P/E ratio of 27.73.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Avanos Medical, Inc. is a medical technology company, which focuses on delivering clinically medical device solutions to improve patients’ quality of life. Its portfolio of innovative product offerings focused on respiratory and digestive health, along with surgical and interventional pain management to improve patient outcomes and reduce the cost of care. Its brands include ON-Q, Coolife, Microcuff, MIC-Key, Quilbloc and Home pump. The company was founded on February 25, 2014 and is headquartered in Alpharetta, GA.
Read More on AVNS:
